February 3, 2014
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
January 15, 2014
Collegium Pharmaceutical Announces Positive Topline Results of Human Abuse Potential Study Evaluating Intranasal Administration of Crushed Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Product
January 13, 2014
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
© 2008 Longitude Capital Management Co., LLC. All rights reserved.
Website Design by IZD